Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sophia Adamia

Isocitrate Dehydrogenase 1 and 2 Mutations, 2-Hydroxyglutarate Levels, and Response to Standard Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia

Cancer

Cancer Research

Oncology

2018

English

Effects of the Multi‐kinase Inhibitor Midostaurin in Combination With Chemotherapy in Models of Acute Myeloid Leukaemia

Journal of Cellular and Molecular Medicine

Molecular Medicine

Cell Biology

2020

English

Related publications

2-Hydroxyglutarate (2-Hg); Isocitrate Dehydrogenase 1 (IDH1)

Science-Business eXchange

2013

English

Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors

World Journal of Oncology

Cancer Research

Oncology

2019

English

Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase (IDH) Mutations in Gliomas

Clinical Cancer Research

Cancer Research

Oncology

2019

English

2-Hydroxyglutarate inIDHmutant Acute Myeloid Leukemia: Predicting Patient Responses, Minimal Residual Disease and Correlations With Methylcytosine and Hydroxymethylcytosine Levels

Leukemia and Lymphoma

English

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia With an Isocitrate Dehydrogenase-1 Mutation

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy

Clinical Lymphoma, Myeloma and Leukemia

English

Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

American Journal of Hematology

Hematology

2018

English

Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)

English

Conditions for 13C NMR Detection of 2-Hydroxyglutarate in Tissue Extracts From Isocitrate Dehydrogenase-Mutated Gliomas

Analytical Biochemistry

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sophia Adamia

Isocitrate Dehydrogenase 1 and 2 Mutations, 2-Hydroxyglutarate Levels, and Response to Standard Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia

Effects of the Multi‐kinase Inhibitor Midostaurin in Combination With Chemotherapy in Models of Acute Myeloid Leukaemia

Related publications

2-Hydroxyglutarate (2-Hg); Isocitrate Dehydrogenase 1 (IDH1)

Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors

Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase (IDH) Mutations in Gliomas

2-Hydroxyglutarate inIDHmutant Acute Myeloid Leukemia: Predicting Patient Responses, Minimal Residual Disease and Correlations With Methylcytosine and Hydroxymethylcytosine Levels

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia With an Isocitrate Dehydrogenase-1 Mutation

Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy

Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)

Conditions for 13C NMR Detection of 2-Hydroxyglutarate in Tissue Extracts From Isocitrate Dehydrogenase-Mutated Gliomas